Additionally, since we showed that Cyr61 can upregulate TF expression in tumour cells, and TF is known to drive tumour growth47, our data reveal a parallel mechanism by which pericyte regulation of Cyr61 and subsequent tumour cell TF drives accelerated tumour growth in the absence of pericyte FAK in vivo. The gene discussed is PTK2; the disease is neoplasm.